GlassScriptPhysician profile
Isaac C Meier
NPI 1821404518
$803.10
in general payments reported to CMS, 2019-2025
12 companies · $97.50 in 2025
The $97.50 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.75 · 2020: $15.59 · 2021: $29.45 · 2022: $171 · 2023: $164 · 2024: $312 · 2025: $97.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $228.33 | 2022-2025 | Corevalve Evolut R, Symplicity G3, Complete Se Vascular |
| Inari Medical, INC. | $153.26 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $146.68 | 2023-2024 | Diamondback Coronary, Optis |
| Philips North America LLC | $81.30 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $43.60 | 2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $41.16 | 2021-2022 | |
| Terumo Medical Corporation | $29.34 | 2019-2020 | |
| Pfizer INC. | $26.93 | 2022 | |
| Abiomed | $17.49 | 2024 | Impella |
| Boston Scientific Corporation | $15.23 | 2025 | Spaceoar Vue System - 10ml |
| Amgen INC. | $13.23 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.55 | 2022-2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Meier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.